Department for Business, Energy & Industrial Strategy
Vaccines Manufacturing and Innovation Centre to open 12 months ahead of schedule
Race to manufacture millions of doses of a coronavirus vaccine boosted with a multi-million-pound government investment.
- Up to £93 million government investment to open the UK’s first dedicated Vaccine Manufacturing and Innovation Centre 12 months early
- A further £38 million will establish a rapid deployment facility this summer
- The new Centre is a key component of the government’s coronavirus programme in boosting the UK’s capacity to develop and mass produce vaccines
The race to manufacture millions of doses of a coronavirus vaccine has been boosted with a multi-million-pound government investment, Business Secretary Alok Sharma yesterday announced.
The government will invest up to £93 million to accelerate construction of the new Vaccines Manufacturing and Innovation Centre (VMIC) which, when completed, will have capacity to produce enough vaccine doses to serve the entire UK population in as little as six months. The funding will ensure the centre opens in Summer 2021, a full 12 months ahead of schedule.
The new Centre, which is already under construction, is a key component of the government’s coronavirus vaccine programme – ensuring that once a vaccine is available it can be produced quickly and in mass quantities.
To be located on the Harwell Science and Innovation Campus in Oxfordshire, the new Centre will be the UK’s first not-for-profit organisation established to develop and advance the mass production of vaccines. This will boost the UK’s long-term capacity against future viruses. The centre will also accelerate the production of vaccines for existing illnesses such as the flu virus.
While the Centre is being built, the government will establish a rapid deployment facility thanks to a further investment of £38 million to begin manufacturing at scale from Summer 2020. This facility will support efforts to ensure a vaccine is widely available to the public as soon as possible.
Business Secretary Alok Sharma yesterday said:
As the biggest contributor to the international coalition to find a vaccine, the UK is leading the global response. Once a breakthrough is made, we need to be ready to manufacture a vaccine by the millions.
The new Vaccine Manufacturing and Innovation Centre and temporary facility will build ‘fill and finish’ capacity, bringing the UK vaccine programme together from discovery to distribution.
The Vaccines Manufacturing and Innovation Centre’s Chief Executive Dr Matthew Duchars yesterday said:
Today’s announcement by the Business Secretary is an important endorsement for the work the Vaccine Manufacturing and Innovation Centre will deliver in shoring up future domestic supply of vaccines in response to a pandemic.
This investment will rapidly accelerate the construction of the facility, enabling us to bring it online a year sooner. In addition, the capacity will be significantly increased, so that enough vaccines could be made for everyone in the UK within a matter of months of opening.
UK Research and Innovation Chef Executive Sir Mark Walport, yesterday said:
The Vaccines Manufacturing and Innovation Centre is an essential new weapon in the UK’s arsenal against diseases and other biological threats, ensuring sufficient vaccines get to the public in the fastest possible time.
The UKRI-funded teams at the University of Oxford and Imperial College London have developed potential coronavirus vaccines at unprecedented speed. By working with partners including government, VMIC and the Vaccines Taskforce to fast-track the manufacturing capability, we are ensuring that momentum will continue all the way from lab to patient.
The UK is at the forefront of international efforts to research and develop a vaccine. The government has already pledged £250 million to the Coalition for Epidemic Preparedness Innovations (CEPI), the highest contribution of any country, and the UK is hosting the upcoming global pledging conference for Gavi, the Vaccine Alliance, on 4 June. This is part of the UK committing £388 million to the international drive to develop vaccines, tests and treatments.
The announcement follows the government appointing leading figure in the life sciences sector Kate Bingham as chair of the UK’s Vaccine Taskforce – the group set up by the Government’s Chief Scientific Adviser, Deputy Chief Medical Officer and Business Secretary to lead UK efforts to find and manufacture a COVID-19 vaccine.
Notes to Editors
- Plans for the Vaccines Manufacturing and Innovation Centre have received a total public and private sector funding of £207 million, including the new £131 million investment.
- The Vaccines Taskforce is supported by an Expert Advisory Board, led by Chief Scientific Adviser Sir Patrick Vallance and Deputy Chief Medical Officer Jonathan Van Tam, to coordinate efforts to accelerate the development and manufacture of a COVID-19 vaccine.
Latest News from
Department for Business, Energy & Industrial Strategy
International supercomputer pact set to fire up UK COVID-19 research29/05/2020 12:20:00
The UK will be the first country, outside the US, to join the global COVID-19 High Performance Computing (HPC) consortium
Up to £15 million to support the Citizens Advice service during COVID-19 pandemic26/05/2020 14:20:00
Citizens Advice and Citizens Advice Scotland to receive funding boost of up to £15 million to help them deal with increased demand during the COVID-19 pandemic.
Government launches new £40 million Clean Growth Fund to supercharge green start-ups22/05/2020 08:10:00
Clean Growth Fund launched as a venture capital vehicle to accelerate early-stage green businesses.
Government introduces legislation to relieve burden on businesses and support economic recovery21/05/2020 15:10:00
The government has introduced the Corporate Governance and Insolvency Bill in Parliament.
£40m boost for cutting-edge start-ups21/05/2020 11:20:00
Innovative businesses and start-ups are set to benefit from a £40 million government investment to drive forward new technological advances.
Funding and manufacturing boost for UK vaccine programme19/05/2020 11:20:00
UK’s top researchers rapidly working to find a coronavirus vaccine will benefit from £84 million of new government funding.
Kate Bingham appointed chair of UK Vaccine Taskforce18/05/2020 15:10:00
Kate Bingham has been appointed chair of the UK’s Vaccine Taskforce
Clare Chapman appointed Chair of Acas18/05/2020 12:20:00
Business Secretary Alok Sharma appoints Clare Chapman as Chair of the Advisory, Conciliation and Arbitration Service (Acas) Council.
Regulations temporarily suspended to fast-track supplies of PPE to NHS staff and protect companies hit by COVID-1915/05/2020 16:15:00
New measures announced yesterday will give vital support to frontline NHS staff battling COVID-19 and support businesses under pressure as a result of the coronavirus outbreak.